For example, BCL6 played a tumor-promoting role in breast cancer and most lymphomas, whereas it could act as a tumor suppressor in medulloblastoma and HB-EGF-CTF-positive GC [3, 6–8]. This evidence concerns the gene HBEGF and lymphoma.